RhumbLine Advisers’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-455
Closed -$1.94K 4375
2023
Q2
$1.94K Sell
455
-15,191
-97% -$86.1K ﹤0.01% 4220
2023
Q1
$88K Buy
15,646
+202
+1% +$1.53K ﹤0.01% 2868
2022
Q4
$128K Buy
15,444
+11,484
+290% +$225K ﹤0.01% 2873
2022
Q3
$128K Buy
3,960
+249
+7% +$9.23K ﹤0.01% 2974
2022
Q2
$149K Buy
+3,711
New +$271K ﹤0.01% 2994

Other funds holding SNCE

RhumbLine Advisers's SNCE Position: Q3 2023 in Review

RhumbLine Advisers sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q3 2023, closing a stake of 455 shares — an estimated $1.94K sold.

RhumbLine Advisers first reported a position in SNCE in Q2 2022 and held it in 5 quarters. The position peaked at $149K in Q2 2022. 43 funds tracked by Wall St. Rank hold SNCE as of Q3 2023.

  • RhumbLine Advisers reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • RhumbLine Advisers sold 455 Science 37 Holdings, Inc. Common Stock shares in Q3 2023, an estimated $1.94K.
  • RhumbLine Advisers first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • RhumbLine Advisers's Science 37 Holdings, Inc. Common Stock position peaked at $149K in Q2 2022.
  • 43 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2023.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.